Switch to:
Also traded in: Germany, Switzerland, UK

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash-to-Debt 1.29
CLHLF's Cash-to-Debt is ranked lower than
54% of the 205 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.74 vs. CLHLF: 1.29 )
Ranked among companies with meaningful Cash-to-Debt only.
CLHLF' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.09  Med: 0.37 Max: 4.21
Current: 1.29
0.09
4.21
Equity-to-Asset 0.71
CLHLF's Equity-to-Asset is ranked higher than
67% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. CLHLF: 0.71 )
Ranked among companies with meaningful Equity-to-Asset only.
CLHLF' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.57  Med: 0.64 Max: 0.71
Current: 0.71
0.57
0.71
Debt-to-Equity 0.08
CLHLF's Debt-to-Equity is ranked higher than
82% of the 142 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.37 vs. CLHLF: 0.08 )
Ranked among companies with meaningful Debt-to-Equity only.
CLHLF' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.02  Med: 0.22 Max: 0.49
Current: 0.08
0.02
0.49
Debt-to-EBITDA 0.27
CLHLF's Debt-to-EBITDA is ranked higher than
87% of the 109 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.88 vs. CLHLF: 0.27 )
Ranked among companies with meaningful Debt-to-EBITDA only.
CLHLF' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.09  Med: 0.84 Max: 1.99
Current: 0.27
0.09
1.99
Interest Coverage 20.87
CLHLF's Interest Coverage is ranked lower than
66% of the 137 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 63.92 vs. CLHLF: 20.87 )
Ranked among companies with meaningful Interest Coverage only.
CLHLF' s Interest Coverage Range Over the Past 10 Years
Min: 6.89  Med: 22.7 Max: 69.39
Current: 20.87
6.89
69.39
Piotroski F-Score: 9
Altman Z-Score: 8.27
Beneish M-Score: -2.57
WACC vs ROIC
4.23%
16.61%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 14.94
CLHLF's Operating Margin % is ranked higher than
79% of the 201 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.41 vs. CLHLF: 14.94 )
Ranked among companies with meaningful Operating Margin % only.
CLHLF' s Operating Margin % Range Over the Past 10 Years
Min: 8.38  Med: 13.32 Max: 15.27
Current: 14.94
8.38
15.27
Net Margin % 9.88
CLHLF's Net Margin % is ranked higher than
69% of the 201 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.18 vs. CLHLF: 9.88 )
Ranked among companies with meaningful Net Margin % only.
CLHLF' s Net Margin % Range Over the Past 10 Years
Min: 3.87  Med: 9.13 Max: 28.88
Current: 9.88
3.87
28.88
ROE % 15.33
CLHLF's ROE % is ranked higher than
76% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.43 vs. CLHLF: 15.33 )
Ranked among companies with meaningful ROE % only.
CLHLF' s ROE % Range Over the Past 10 Years
Min: 6.13  Med: 14.22 Max: 34.48
Current: 15.33
6.13
34.48
ROA % 10.57
CLHLF's ROA % is ranked higher than
80% of the 206 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.85 vs. CLHLF: 10.57 )
Ranked among companies with meaningful ROA % only.
CLHLF' s ROA % Range Over the Past 10 Years
Min: 3.67  Med: 9.42 Max: 23.5
Current: 10.57
3.67
23.5
ROC (Joel Greenblatt) % 30.64
CLHLF's ROC (Joel Greenblatt) % is ranked higher than
75% of the 204 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.63 vs. CLHLF: 30.64 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
CLHLF' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 13.19  Med: 23.95 Max: 31.04
Current: 30.64
13.19
31.04
3-Year Revenue Growth Rate 0.10
CLHLF's 3-Year Revenue Growth Rate is ranked lower than
66% of the 170 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.10 vs. CLHLF: 0.10 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
CLHLF' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -12.2  Med: 0.1 Max: 3
Current: 0.1
-12.2
3
3-Year EBITDA Growth Rate 8.40
CLHLF's 3-Year EBITDA Growth Rate is ranked lower than
60% of the 155 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.00 vs. CLHLF: 8.40 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
CLHLF' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -17.6  Med: -0.8 Max: 20.7
Current: 8.4
-17.6
20.7
3-Year EPS without NRI Growth Rate 9.40
CLHLF's 3-Year EPS without NRI Growth Rate is ranked lower than
56% of the 155 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 12.90 vs. CLHLF: 9.40 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
CLHLF' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -29.5  Med: 0.1 Max: 39.7
Current: 9.4
-29.5
39.7
GuruFocus has detected 5 Warning Signs with Coltene Holding AG CLHLF.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» CLHLF's 30-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with CLHLF

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS: 339114 
Compare:SHSE:603880, ROCO:6491, SZSE:300030, NAS:UTMD, XKRX:049180, NAS:ATRS, NAS:ELGX, SZSE:300246, XKRX:119610, XSWX:VBSN, AMEX:TRXC, BOM:531768, SZSE:300677, SZSE:300453, MIL:SFL, TSE:7749, HKSE:00801, NAS:PLSE, OSTO:ALIF B, TSE:6823 » details
Traded in other countries:M3Z.Germany, CLTN.Switzerland, 0QP7.UK,
Headquarter Location:Switzerland
Coltene Holding AG developes and manufactures dental consumables and small equipment for dental practitioners. It offers products including adhesives and restorative materials, endodontic materials, and prosthetics.

Coltene Holding AG is a Switzerland based company engaged in developing, manufacturing, and selling a range of disposables and tools for dentists and dental laboratories. The product groups manufactured by the company are restoration, prosthetics, endodontics, treatment auxiliaries, treatment auxiliaries, rotary instruments and infection control. It generates key revenue from the restoration product category which includes products ranging from adhesive systems and restorative filling materials to curing equipment. The group sells its products in Asia, Latin America, North America and Europe of which majority of the revenue is derived from Europe.

Ratios

vs
industry
vs
history
PE Ratio 133.64
CLHLF's PE Ratio is ranked higher than
68% of the 125 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.70 vs. CLHLF: 133.64 )
Ranked among companies with meaningful PE Ratio only.
CLHLF' s PE Ratio Range Over the Past 10 Years
Min: 3.65  Med: 18.72 Max: 133.64
Current: 133.64
3.65
133.64
PE Ratio without NRI 133.64
CLHLF's PE Ratio without NRI is ranked higher than
70% of the 123 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. CLHLF: 133.64 )
Ranked among companies with meaningful PE Ratio without NRI only.
CLHLF' s PE Ratio without NRI Range Over the Past 10 Years
Min: 9.92  Med: 19.26 Max: 133.64
Current: 133.64
9.92
133.64
Price-to-Owner-Earnings 111.74
CLHLF's Price-to-Owner-Earnings is ranked higher than
71% of the 83 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.92 vs. CLHLF: 111.74 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
CLHLF' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 10.48  Med: 19.39 Max: 146.71
Current: 111.74
10.48
146.71
PB Ratio 20.58
CLHLF's PB Ratio is ranked lower than
56% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.45 vs. CLHLF: 20.58 )
Ranked among companies with meaningful PB Ratio only.
CLHLF' s PB Ratio Range Over the Past 10 Years
Min: 1.19  Med: 2.23 Max: 20.58
Current: 20.58
1.19
20.58
PS Ratio 13.44
CLHLF's PS Ratio is ranked higher than
59% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.48 vs. CLHLF: 13.44 )
Ranked among companies with meaningful PS Ratio only.
CLHLF' s PS Ratio Range Over the Past 10 Years
Min: 0.71  Med: 1.52 Max: 13.44
Current: 13.44
0.71
13.44
Price-to-Free-Cash-Flow 127.37
CLHLF's Price-to-Free-Cash-Flow is ranked higher than
64% of the 74 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.61 vs. CLHLF: 127.37 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
CLHLF' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 8.87  Med: 15.62 Max: 127.37
Current: 127.37
8.87
127.37
Price-to-Operating-Cash-Flow 95.15
CLHLF's Price-to-Operating-Cash-Flow is ranked higher than
63% of the 94 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.15 vs. CLHLF: 95.15 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
CLHLF' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 7.15  Med: 12.55 Max: 95.15
Current: 95.15
7.15
95.15
EV-to-EBIT 16.99
CLHLF's EV-to-EBIT is ranked higher than
71% of the 121 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.93 vs. CLHLF: 16.99 )
Ranked among companies with meaningful EV-to-EBIT only.
CLHLF' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.5  Med: 13.7 Max: 17.9
Current: 16.99
6.5
17.9
EV-to-EBITDA 13.75
CLHLF's EV-to-EBITDA is ranked higher than
70% of the 138 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.49 vs. CLHLF: 13.75 )
Ranked among companies with meaningful EV-to-EBITDA only.
CLHLF' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.6  Med: 10.5 Max: 14.5
Current: 13.75
5.6
14.5
EV-to-Revenue 2.50
CLHLF's EV-to-Revenue is ranked higher than
61% of the 199 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.57 vs. CLHLF: 2.50 )
Ranked among companies with meaningful EV-to-Revenue only.
CLHLF' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.9  Med: 1.6 Max: 2.6
Current: 2.5
0.9
2.6
PEG Ratio 2.12
CLHLF's PEG Ratio is ranked higher than
51% of the 69 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.70 vs. CLHLF: 2.12 )
Ranked among companies with meaningful PEG Ratio only.
CLHLF' s PEG Ratio Range Over the Past 10 Years
Min: 1.48  Med: 2.7 Max: 8.51
Current: 2.12
1.48
8.51
Shiller PE Ratio 116.67
CLHLF's Shiller PE Ratio is ranked higher than
81% of the 54 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 50.97 vs. CLHLF: 116.67 )
Ranked among companies with meaningful Shiller PE Ratio only.
CLHLF' s Shiller PE Ratio Range Over the Past 10 Years
Min: 12.78  Med: 18.91 Max: 116.67
Current: 116.67
12.78
116.67
Current Ratio 2.89
CLHLF's Current Ratio is ranked higher than
57% of the 200 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.57 vs. CLHLF: 2.89 )
Ranked among companies with meaningful Current Ratio only.
CLHLF' s Current Ratio Range Over the Past 10 Years
Min: 1.21  Med: 1.98 Max: 3.16
Current: 2.89
1.21
3.16
Quick Ratio 1.71
CLHLF's Quick Ratio is ranked lower than
52% of the 201 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.87 vs. CLHLF: 1.71 )
Ranked among companies with meaningful Quick Ratio only.
CLHLF' s Quick Ratio Range Over the Past 10 Years
Min: 0.66  Med: 1.13 Max: 1.83
Current: 1.71
0.66
1.83
Days Inventory 259.64
CLHLF's Days Inventory is ranked lower than
83% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 124.35 vs. CLHLF: 259.64 )
Ranked among companies with meaningful Days Inventory only.
CLHLF' s Days Inventory Range Over the Past 10 Years
Min: 216.41  Med: 248.79 Max: 387.53
Current: 259.64
216.41
387.53
Days Sales Outstanding 70.37
CLHLF's Days Sales Outstanding is ranked lower than
63% of the 165 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.97 vs. CLHLF: 70.37 )
Ranked among companies with meaningful Days Sales Outstanding only.
CLHLF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 68.44  Med: 77.41 Max: 113.51
Current: 70.37
68.44
113.51
Days Payable 40.86
CLHLF's Days Payable is ranked lower than
62% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 54.66 vs. CLHLF: 40.86 )
Ranked among companies with meaningful Days Payable only.
CLHLF' s Days Payable Range Over the Past 10 Years
Min: 35.69  Med: 48.36 Max: 71.26
Current: 40.86
35.69
71.26

Buy Back

vs
industry
vs
history
3-Year Dividend Growth Rate 6.90
CLHLF's 3-Year Dividend Growth Rate is ranked lower than
56% of the 62 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.90 vs. CLHLF: 6.90 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
CLHLF' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: -25.9 Max: 31.5
Current: 6.9
0
31.5
5-Year Yield-on-Cost % 4.89
CLHLF's 5-Year Yield-on-Cost % is ranked higher than
86% of the 209 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.44 vs. CLHLF: 4.89 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
CLHLF' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.42  Med: 4.49 Max: 14.32
Current: 4.89
0.42
14.32

Valuation & Return

vs
industry
vs
history
Price-to-Net-Current-Asset-Value 11.82
CLHLF's Price-to-Net-Current-Asset-Value is ranked lower than
67% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.83 vs. CLHLF: 11.82 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
CLHLF' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 4.75  Med: 10.87 Max: 30.6
Current: 11.82
4.75
30.6
Price-to-Tangible-Book 6.52
CLHLF's Price-to-Tangible-Book is ranked lower than
61% of the 167 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.77 vs. CLHLF: 6.52 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
CLHLF' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.44  Med: 4.25 Max: 6.64
Current: 6.52
2.44
6.64
Price-to-Intrinsic-Value-Projected-FCF 1.80
CLHLF's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
99.99% of the 75 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.41 vs. CLHLF: 1.80 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
CLHLF' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.56  Med: 0.96 Max: 1.8
Current: 1.8
0.56
1.8
Price-to-Median-PS-Value 1.67
CLHLF's Price-to-Median-PS-Value is ranked lower than
99.99% of the 160 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.13 vs. CLHLF: 1.67 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
CLHLF' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.54  Med: 1.01 Max: 1.67
Current: 1.67
0.54
1.67
Price-to-Peter-Lynch-Fair-Value 2.11
CLHLF's Price-to-Peter-Lynch-Fair-Value is ranked lower than
99.99% of the 45 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.46 vs. CLHLF: 2.11 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
CLHLF' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 1.39  Med: 2.68 Max: 2.89
Current: 2.11
1.39
2.89
Price-to-Graham-Number 2.71
CLHLF's Price-to-Graham-Number is ranked higher than
53% of the 94 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.77 vs. CLHLF: 2.71 )
Ranked among companies with meaningful Price-to-Graham-Number only.
CLHLF' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.13  Med: 1.86 Max: 2.76
Current: 2.71
1.13
2.76
Earnings Yield (Greenblatt) % 5.89
CLHLF's Earnings Yield (Greenblatt) % is ranked higher than
83% of the 207 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.40 vs. CLHLF: 5.89 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
CLHLF' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 5.6  Med: 7.3 Max: 15.3
Current: 5.89
5.6
15.3
Forward Rate of Return (Yacktman) % 14.55
CLHLF's Forward Rate of Return (Yacktman) % is ranked higher than
66% of the 101 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.66 vs. CLHLF: 14.55 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
CLHLF' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -3.7  Med: 1.6 Max: 16
Current: 14.55
-3.7
16

More Statistics

Revenue (TTM) (Mil) $164.03
EPS (TTM) $ 3.83
Beta0.39
Volatility5.13%
52-Week Range $61.00 - 61.00
Shares Outstanding (Mil)4.22

Analyst Estimate

Dec17 Dec18 Dec19 Dec20
Revenue (Mil $) 170 179 187 194
EBIT (Mil $) 24 28 30 32
EBITDA (Mil $) 30 34 37 39
EPS ($) 4.18 5.05 5.51 5.84
EPS without NRI ($) 4.18 5.05 5.51 5.84
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($) 3.04 3.55 3.86 4.08

Piotroski F-Score Details

Piotroski F-Score: 99
Positive ROAY
Positive CFROAY
Higher ROA yoyY
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyY
Less Shares Outstanding yoyY
Higher Gross Margin yoyY
Higher Asset Turnover yoyY

» More Articles for CLHLF

Headlines

Articles On GuruFocus.com
Tweedy Browne Hits a Home Run With Coltene Holding Sep 13 2017 

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}